Viewing Study NCT01106235


Ignite Creation Date: 2025-12-24 @ 10:33 PM
Ignite Modification Date: 2025-12-28 @ 6:35 PM
Study NCT ID: NCT01106235
Status: TERMINATED
Last Update Posted: 2011-12-21
First Post: 2010-04-08
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Therapeutic Autologous Lymphocytes, Cyclophosphamide, and Aldesleukin in Treating Patients With Metastatic Melanoma
Sponsor: Fred Hutchinson Cancer Center
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: 2390.00
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: None
Responsible Party Affiliation:
Old Name: Yee, Cassian
Old Organization: Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium

Collaborators

Collaborators

Name Class View
None NIH View